Allarity Therapeutics, Inc. (ALLR)

NASDAQ: ALLR · IEX Real-Time Price · USD

0.168

-0.018 (-9.92%)

At close: Jul 19, 2024, 4:00 PM

0.170

+0.002 (1.07%)

Pre-market: Jul 22, 2024, 9:11 AM EDT

Allarity Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-12.39	-20.42	-21.05	-26.65	-6.6	-14.31
Depreciation & Amortization	0.03	0.04	0.06	0.11	0.09	0.09
Share-Based Compensation	-0.07	-0.07	1.75	6.37	0.62	0.33
Other Operating Activities	1.4	-0.81	-2.57	5.29	-1.35	3.78
Operating Cash Flow	-11.03	-12.75	-16.82	-14.89	-7.25	-10.11
Capital Expenditures	0	0	0.79	1.01	-0	-0.01
Change in Investments	0	0	0	0	0	0.24
Investing Cash Flow	0	0	0.79	1.01	-0	0.23
Share Issuance / Repurchase	16.94	16.9	0	34.89	3.7	13.56
Debt Issued / Paid	-1.31	-2.65	1	0.97	2.55	3.55
Other Financing Activities	-4.41	-3.25	-2.31	-2.04	-0.22	-5.9
Financing Cash Flow	11.22	11	-1.31	33.82	6.03	11.2
Exchange Rate Effect	-0.17	-0.11	-0.19	-0.68	-0.01	-0.03
Net Cash Flow	0.19	-1.75	-17.34	19.94	-1.22	1.32
Free Cash Flow	-11.03	-12.75	-16.03	-13.88	-7.25	-10.12
Free Cash Flow Margin	-	-	-	-	-	-8434.17%
Free Cash Flow Per Share	-0.06	-128.04	-47100.66	-61120.97	-62213.23	-223466.03

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).